secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0001104659-23-010476
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics stockholders approve 55M share increase and 5M share plan increase
--------------------------------------------------------------------------------

- Approved increase in authorized common shares from 20M to 75M (55M increase).
- Approved amendment to 2015 Incentive Plan increasing available shares from 266,666 to 5,266,666.
- Re-elected all five director nominees: Rosenwald, Charles, Herskowitz, Kranzler, Oltmans.
- Ratification of BDO as auditor not voted on due to prior dismissal; KPMG appointed as new auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923010476/0001104659-23-010476-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923010476/tm235221d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-010476

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer